Citigroup Inc

Filing Details

13F-HR • 2025-03-31
SEC
Report Date
2025-03-31
Filing Date
2025-05-12
Total Holdings
8,340
Total Value
44847690535
Accession Number
0000831001-25-000103
Form Type
13F-HR
CIK
0000831001
Manager Name
Citigroup Inc
Data Enrichment
86% identified
7,168 identified1,172 unidentified

Holdings

8,340 positions
Manager:
SEC
Search and click to pin securities to the top
Page 220 of 239
Lyell Immunopharma, Inc.
LYEL|55083R104
Shares:
2591(+459.6%)
Value:
$1.4M(+370.9%)
TSS, Inc.
TSSI|87288V101
Shares:
176
Value:
$1.4M
MediWound Ltd.
MDWD|M68830112
Shares:
89(+535.7%)
Value:
$1.4M(+454.6%)
MARINE PRODUCTS CORP
MPX|568427108
Shares:
164(+65.7%)
Value:
$1.4M(+51.5%)
Kodiak Sciences Inc.
KOD|50015M109
Shares:
490(+228.8%)
Value:
$1.4M(-7.3%)
Citi Trends Inc
CTRN|17306X102
Shares:
62(+520.0%)
Value:
$1.4M(+421.7%)
Brand Engagement Network Inc.
BNAIW|104932116
Shares:
66667(+0.0%)
Value:
$1.4M(-63.6%)
ONE Group Hospitality, Inc.
STKS|88338K103
Shares:
454(+284.7%)
Value:
$1.4M(+296.8%)
08659B102
08659B102
Shares:
110
Value:
$1.3M
68248T204
68248T204
Shares:
200(+0.0%)
Value:
$1.3M(+175.7%)
ROCKY BRANDS, INC.
RCKY|774515100
Shares:
77(+305.3%)
Value:
$1.3M(+208.3%)
SMITH MIDLAND CORP
SMID|832156103
Shares:
43(+514.3%)
Value:
$1.3M(+329.6%)
Neurogene Inc.
NGNE|64135M105
Shares:
114(+533.3%)
Value:
$1.3M(+224.8%)
InflaRx N.V.
IFRX|N44821101
Shares:
1301(+0.0%)
Value:
$1.3M(-58.7%)
PUMA BIOTECHNOLOGY, INC.
PBYI|74587V107
Shares:
447(+425.9%)
Value:
$1.3M(+410.8%)
Cartesian Therapeutics, Inc.
RNAC|816212302
Shares:
99(+482.4%)
Value:
$1.3M(+327.9%)
PepGen Inc.
PEPG|713317105
Shares:
918(+2681.8%)
Value:
$1.3M(+932.0%)
CS Disco, Inc.
LAW|126327105
Shares:
311(+80.8%)
Value:
$1.3M(+48.3%)
NEKTAR THERAPEUTICS
NKTR|640268108
Shares:
1864(+335.5%)
Value:
$1.3M(+218.3%)
ACACIA RESEARCH CORP
ACTG|003881307
Shares:
395(+129.7%)
Value:
$1.3M(+69.4%)